Data as of Mar 11
| +0.08 / +1.84%|
The 3 analysts offering 12-month price forecasts for China Cord Blood Corp have a median target of 5.50, with a high estimate of 7.00 and a low estimate of 5.00. The median estimate represents a +24.43% increase from the last price of 4.42.
The current consensus among 3 polled investment analysts is to Buy stock in China Cord Blood Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.